Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-23

Clinical Trial Update: Efficacy of Liraglutide Therapy in Patients With IPAA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liraglutide for pouchitis and irritable pouch syndrome in patients with ileal pouch-anal anastomosis has been terminated. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Pouchitis, Irritable Pouch Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2024-07-23